BACKGROUND: There are scant data regarding oncologic outcomes of laparoscopic liver resection (LLR). The aim of this study is to analyze the oncologic outcomes of LLR for malignant @entity96 (MLT). METHODS: This was a prospective IRB-approved study of 123 @entity1 with MLT undergoing LLR. Kaplan-Meier disease-free (DFS) and @entity1349 ( @entity1349 ) was calculated. RESULTS: Tumor type was colorectal in 61%, @entity96 in 21%, neuroendocrine in 5% and others in 13%. Mean @entity5 size was 3.2        1.9   cm and number of @entity5 1.6        1.2. A wedge resection or segmentectomy was performed in 63.4%, bisegmentectomy in 24.4%, and hemihepatectomy in 12.2%. Procedures were totally laparoscopic in 67% and hand-assisted in 33%. Operative time was 235.2        94.3   min, and conversion rate 7.3%. An R0 resection was achieved in 90% of @entity1 and 94% of @entity5 . Median hospital stay was 3 days. Morbidity was 22% and mortality 0.8%. For @entity1 with @entity14 , DFS and @entity1349 at 2 years was 47% and 88%, respectively. CONCLUSIONS: This study shows that LLR is a safe and efficacious treatment for selected @entity1 with MLT. Complete resection and margin recurrence rate are comparable to open series in the literature. J. Surg. Oncol. 2016;113:127-129.    2015 Wiley Periodicals, Inc.

Oncologic results of laparoscopic liver resection for malignant XXXX .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity96 :: ('MESH:D008113', 'Disease') :: ['liver tumors', 'hepatocellular cancer'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor', 'tumors'] @entity14 :: ('MESH:D015179', 'Disease') :: ['colorectal liver metastasis'] @entity1349 :: ('MESH:D011475', 'Disease') :: ['OS', 'overall survival']
@entity96 :: (MESH:D008113,Disease) :: ['liver tumors']
